Clovis Oncology Inc
NASDAQ:CLVS
Income Statement
Earnings Waterfall
Clovis Oncology Inc
Revenue
|
133m
USD
|
Cost of Revenue
|
-37m
USD
|
Gross Profit
|
96.1m
USD
|
Operating Expenses
|
-302.7m
USD
|
Operating Income
|
-206.7m
USD
|
Other Expenses
|
-45.2m
USD
|
Net Income
|
-251.9m
USD
|
Income Statement
Clovis Oncology Inc
Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
14
N/A
|
14
N/A
|
14
N/A
|
14
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
7
+8 813%
|
22
+205%
|
39
+77%
|
56
+44%
|
67
+21%
|
76
+14%
|
82
+8%
|
95
+16%
|
110
+15%
|
119
+8%
|
134
+12%
|
143
+7%
|
152
+7%
|
159
+5%
|
161
+1%
|
165
+2%
|
160
-3%
|
157
-2%
|
156
-1%
|
149
-5%
|
145
-3%
|
140
-3%
|
133
-5%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(5)
|
(8)
|
(12)
|
(15)
|
(17)
|
(19)
|
(22)
|
(26)
|
(29)
|
(33)
|
(35)
|
(36)
|
(39)
|
(40)
|
(41)
|
(41)
|
(40)
|
(40)
|
(39)
|
(39)
|
(38)
|
(37)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
6
+55 100%
|
17
+209%
|
30
+79%
|
44
+44%
|
52
+20%
|
59
+13%
|
63
+6%
|
73
+16%
|
84
+14%
|
91
+8%
|
102
+12%
|
108
+7%
|
116
+7%
|
120
+4%
|
121
+1%
|
123
+2%
|
119
-3%
|
117
-2%
|
116
-1%
|
110
-5%
|
106
-3%
|
102
-4%
|
96
-6%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(70)
|
(70)
|
(74)
|
(76)
|
(83)
|
(97)
|
(112)
|
(131)
|
(159)
|
(193)
|
(227)
|
(271)
|
(300)
|
(321)
|
(330)
|
(309)
|
(292)
|
(269)
|
(261)
|
(272)
|
(281)
|
(303)
|
(331)
|
(363)
|
(407)
|
(434)
|
(455)
|
(474)
|
(476)
|
(480)
|
(473)
|
(450)
|
(425)
|
(428)
|
(368)
|
(349)
|
(330)
|
(327)
|
(319)
|
(303)
|
|
Selling, General & Administrative |
(11)
|
(11)
|
(12)
|
(14)
|
(17)
|
(19)
|
(20)
|
(21)
|
(21)
|
(23)
|
(25)
|
(28)
|
(31)
|
(34)
|
(36)
|
(37)
|
(41)
|
(60)
|
(87)
|
(113)
|
(139)
|
(149)
|
(158)
|
(165)
|
(176)
|
(184)
|
(187)
|
(187)
|
(183)
|
(178)
|
(171)
|
(168)
|
(164)
|
(151)
|
(142)
|
(136)
|
(128)
|
(128)
|
(127)
|
(126)
|
|
Research & Development |
(59)
|
(58)
|
(62)
|
(62)
|
(67)
|
(79)
|
(91)
|
(110)
|
(138)
|
(170)
|
(202)
|
(243)
|
(269)
|
(287)
|
(294)
|
(273)
|
(251)
|
(209)
|
(174)
|
(159)
|
(143)
|
(154)
|
(173)
|
(198)
|
(231)
|
(250)
|
(268)
|
(282)
|
(283)
|
(289)
|
(288)
|
(273)
|
(258)
|
(242)
|
(218)
|
(202)
|
(187)
|
(176)
|
(167)
|
(151)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(10)
|
(13)
|
(14)
|
(8)
|
(4)
|
(35)
|
(8)
|
(11)
|
(15)
|
(23)
|
(25)
|
(26)
|
|
Operating Income |
(70)
N/A
|
(70)
-1%
|
(74)
-6%
|
(76)
-3%
|
(83)
-9%
|
(84)
-1%
|
(98)
-17%
|
(118)
-20%
|
(146)
-23%
|
(193)
-33%
|
(227)
-18%
|
(271)
-19%
|
(300)
-10%
|
(321)
-7%
|
(330)
-3%
|
(309)
+6%
|
(292)
+6%
|
(264)
+10%
|
(244)
+7%
|
(241)
+1%
|
(238)
+1%
|
(250)
-5%
|
(271)
-9%
|
(300)
-11%
|
(334)
-11%
|
(350)
-5%
|
(365)
-4%
|
(373)
-2%
|
(367)
+1%
|
(364)
+1%
|
(353)
+3%
|
(329)
+7%
|
(302)
+8%
|
(309)
-2%
|
(251)
+19%
|
(233)
+7%
|
(220)
+5%
|
(220)
0%
|
(217)
+2%
|
(207)
+5%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(1)
|
(5)
|
(6)
|
(6)
|
(9)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(10)
|
(12)
|
(12)
|
(14)
|
(15)
|
(15)
|
(17)
|
(20)
|
(23)
|
(25)
|
(26)
|
(26)
|
(28)
|
(31)
|
(35)
|
(37)
|
(39)
|
(42)
|
(44)
|
|
Non-Reccuring Items |
(4)
|
(1)
|
(0)
|
(0)
|
(1)
|
(13)
|
(14)
|
(15)
|
(13)
|
(1)
|
(1)
|
(12)
|
(77)
|
(77)
|
(155)
|
(143)
|
(81)
|
(80)
|
(118)
|
(118)
|
(105)
|
(113)
|
(16)
|
(16)
|
(28)
|
(20)
|
(25)
|
(18)
|
(18)
|
(26)
|
(4)
|
(11)
|
(38)
|
0
|
(29)
|
(33)
|
(8)
|
0
|
(6)
|
(2)
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
2
|
3
|
3
|
3
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
5
|
6
|
7
|
8
|
9
|
9
|
8
|
6
|
1
|
(1)
|
(2)
|
(3)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
1
|
|
Pre-Tax Income |
(74)
N/A
|
(71)
+4%
|
(74)
-5%
|
(76)
-3%
|
(84)
-11%
|
(97)
-15%
|
(113)
-16%
|
(132)
-17%
|
(158)
-20%
|
(192)
-22%
|
(229)
-19%
|
(289)
-26%
|
(382)
-32%
|
(406)
-6%
|
(493)
-21%
|
(460)
+7%
|
(381)
+17%
|
(352)
+8%
|
(370)
-5%
|
(366)
+1%
|
(350)
+4%
|
(369)
-6%
|
(294)
+20%
|
(322)
-10%
|
(367)
-14%
|
(376)
-2%
|
(395)
-5%
|
(400)
-1%
|
(399)
+0%
|
(411)
-3%
|
(383)
+7%
|
(367)
+4%
|
(370)
-1%
|
(337)
+9%
|
(311)
+8%
|
(300)
+4%
|
(265)
+12%
|
(259)
+2%
|
(264)
-2%
|
(252)
+4%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(2)
|
(3)
|
(2)
|
(0)
|
(0)
|
1
|
29
|
33
|
62
|
62
|
32
|
28
|
0
|
1
|
166
|
166
|
165
|
163
|
(1)
|
(1)
|
(1)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(74)
|
(71)
|
(74)
|
(76)
|
(85)
|
(100)
|
(115)
|
(134)
|
(160)
|
(192)
|
(229)
|
(288)
|
(353)
|
(373)
|
(431)
|
(398)
|
(349)
|
(324)
|
(370)
|
(365)
|
(184)
|
(203)
|
(129)
|
(158)
|
(368)
|
(377)
|
(396)
|
(400)
|
(400)
|
(413)
|
(385)
|
(370)
|
(369)
|
(336)
|
(310)
|
(299)
|
(265)
|
(258)
|
(263)
|
(252)
|
|
Net Income (Common) |
(74)
N/A
|
(71)
+5%
|
(74)
-5%
|
(76)
-3%
|
(85)
-11%
|
(100)
-18%
|
(115)
-15%
|
(134)
-17%
|
(160)
-19%
|
(192)
-20%
|
(229)
-19%
|
(288)
-26%
|
(353)
-22%
|
(373)
-6%
|
(431)
-15%
|
(398)
+8%
|
(349)
+12%
|
(324)
+7%
|
(370)
-14%
|
(365)
+1%
|
(346)
+5%
|
(366)
-6%
|
(291)
+20%
|
(321)
-10%
|
(368)
-15%
|
(377)
-2%
|
(396)
-5%
|
(400)
-1%
|
(400)
0%
|
(413)
-3%
|
(385)
+7%
|
(370)
+4%
|
(369)
+0%
|
(336)
+9%
|
(310)
+8%
|
(299)
+4%
|
(265)
+12%
|
(258)
+2%
|
(263)
-2%
|
(252)
+4%
|
|
EPS (Diluted) |
-2.85
N/A
|
-2.71
+5%
|
-2.78
-3%
|
-2.54
+9%
|
-2.65
-4%
|
-2.94
-11%
|
-3.4
-16%
|
-3.96
-16%
|
-4.72
-19%
|
-5.66
-20%
|
-6.72
-19%
|
-7.66
-14%
|
-9.2
-20%
|
-9.73
-6%
|
-11.22
-15%
|
-10.33
+8%
|
-9.04
+12%
|
-7.36
+19%
|
-8.2
-11%
|
-7.47
+9%
|
-6.93
+7%
|
-7.23
-4%
|
-5.58
+23%
|
-6.09
-9%
|
-6.98
-15%
|
-7.12
-2%
|
-7.47
-5%
|
-7.31
+2%
|
-7.3
+0%
|
-5.77
+21%
|
-4.79
+17%
|
-4.19
+13%
|
-3.82
+9%
|
-3.22
+16%
|
-2.86
+11%
|
-2.47
+14%
|
-2.07
+16%
|
-1.87
+10%
|
-1.83
+2%
|
-1.74
+5%
|